Drug details
Gleevec (imatinib mesylate)
type of Antineoplastic Tyrosine Kinase Inhibitors, PDGFR-alpha Inhibitors
Gleevec (imatinib mesylate) is a kinase inhibitor that inhibits a protein signal that causes cancer cell proliferation used to treat patients with hematological malignancies or malignant sarcomas such as Philadelphia positive chronic myeloid leukemia, chronic myeloid leukemia in blast crisis, acute lymphoblastic leukemia, aggressive systemic mastocytosis, gastrointestinal stromal tumors, and other diseases. Gleevec is available in generic form.
This drug may have the following side effects:
- dizziness,
- nausea,
- blurred vision,
- headache
- vomiting,
- diarrhea,
- muscle or joint pain,
- skin rash,
- drowsiness,
- stomach pain or upset,
- stuffy nose, or
- feeling tired,
- gas,
- muscle cramps,
- flu-like symptoms,
- sinus pain.
The following drugs are related to Gleevec, either as a replacement or used together:
- Alecensa (alectinib capsules)
- Arzerra (ofatumumab injection)
- Rylaze (asparaginase erwinia chrysanthemi (recombinant) - rywn) injection)
- Asparlas (calaspargase pegol-mknl injection)
- Symbenda (bendamustine hydrochloride)
- Bendeka (bendamustine hydrochloride injection)
- Blincyto (blinatumomab for injection)
- Bosulif (bosutinib tablets)
- Sprycel (dasatinib)
- Inqovi (decitabine and cedazuridine tablets)
- Elzonris (tagraxofusp-erzs injection)
- Toposar (etoposide injection)
- Nivestym (filgrastim-aafi injection)
- Oforta (fludarabine phosphate tablets)
- Zydelig (idelalisib tablets)
- Tibsovo (ivosidenib tablets)
- Jakafi (ruxolitinib)
- Lumoxiti (moxetumomab pasudotox-tdfk for injection)
- Purinethol (mercaptopurine)
- Purixan (mercaptopurine oral suspension)
- Rydapt (midostaurin capsules)
- Tasigna Capsules (nilotinib capsules)
- Synribo (omacetaxine mepesuccinate)
- Udenyca (pegfilgrastim-cbqv injection)
The following supplements are related to Gleevec, and may be used together with the drug:
- Saccharomyces Boulardii (s.)
- Arsenic (s.)
- Transfer Factor (s.)